Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01441596 |
|---|---|
| Brief Title: | Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases |
| First Submitted : | September 26, 2011 |
| First Submitted that Met QC Criteria : | September 26, 2011 |
| First Posted : | September 27, 2011 (Estimate) |
| Results First Submitted : | February 10, 2015 |
| Results First Submitted that Met QC Criteria : | February 10, 2015 |
| Results First Posted : | February 25, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 25, 2015 |
| Last Update Posted : | September 7, 2015 (Estimate) |